SG10202103336SA - Novel coelenterazine substrates and methods of use - Google Patents
Novel coelenterazine substrates and methods of useInfo
- Publication number
- SG10202103336SA SG10202103336SA SG10202103336SA SG10202103336SA SG10202103336SA SG 10202103336S A SG10202103336S A SG 10202103336SA SG 10202103336S A SG10202103336S A SG 10202103336SA SG 10202103336S A SG10202103336S A SG 10202103336SA SG 10202103336S A SG10202103336S A SG 10202103336SA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- novel coelenterazine
- coelenterazine substrates
- substrates
- novel
- Prior art date
Links
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical compound C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 title 2
- 239000000758 substrate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
- C12Y113/12005—Renilla-luciferin 2-monooxygenase (1.13.12.5), i.e. renilla-luciferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
- C12Y113/12007—Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
- C12Y113/12013—Oplophorus-luciferin 2-monooxygenase (1.13.12.13)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40942210P | 2010-11-02 | 2010-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202103336SA true SG10202103336SA (en) | 2021-04-29 |
Family
ID=44983728
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202103336SA SG10202103336SA (en) | 2010-11-02 | 2011-11-02 | Novel coelenterazine substrates and methods of use |
| SG10201607774RA SG10201607774RA (en) | 2010-11-02 | 2011-11-02 | Novel coelenterazine substrates and methods of use |
| SG10201608550SA SG10201608550SA (en) | 2010-11-02 | 2011-11-02 | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| SG2013033675A SG190104A1 (en) | 2010-11-02 | 2011-11-02 | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| SG2013030366A SG189496A1 (en) | 2010-11-02 | 2011-11-02 | Novel coelenterazine substrates and methods of use |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201607774RA SG10201607774RA (en) | 2010-11-02 | 2011-11-02 | Novel coelenterazine substrates and methods of use |
| SG10201608550SA SG10201608550SA (en) | 2010-11-02 | 2011-11-02 | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| SG2013033675A SG190104A1 (en) | 2010-11-02 | 2011-11-02 | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| SG2013030366A SG189496A1 (en) | 2010-11-02 | 2011-11-02 | Novel coelenterazine substrates and methods of use |
Country Status (15)
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2308978B8 (en) | 2003-10-10 | 2015-04-08 | Promega Corporation | Luciferase biosensor |
| WO2007120522A2 (en) | 2006-04-03 | 2007-10-25 | Promega Corporation | Permuted and nonpermuted luciferase biosensors |
| JP6110591B2 (ja) | 2008-05-19 | 2017-04-05 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | ｃＡＭＰのためのルシフェラーゼバイオセンサー |
| SG10201601281WA (en) * | 2009-05-01 | 2016-03-30 | Promega Corp | Synthetic oplophorus luciferases with enhanced light output |
| EP2990479B1 (en) | 2010-05-11 | 2019-03-27 | Promega Corporation | Mutant protease biosensors with enhanced detection characteristics |
| US9290794B2 (en) * | 2010-05-11 | 2016-03-22 | Promega Corporation | Mutant protease biosensors with enhanced detection characteristics |
| BR112013010855A2 (pt) * | 2010-11-02 | 2017-06-27 | Promega Corp | luciferases derivadas de oplophorus, novos substratos de coelenterazina e métodos de uso |
| PT2635583E (pt) | 2010-11-02 | 2015-09-11 | Promega Corp | Derivados da coelenterazina e métodos de utilização da mesma |
| US9056885B2 (en) | 2011-11-21 | 2015-06-16 | Promega Corporation | Carboxy X rhodamine analogs |
| US10067149B2 (en) | 2012-12-12 | 2018-09-04 | Promega Corporation | Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer |
| KR102150479B1 (ko) * | 2012-12-12 | 2020-09-01 | 프로메가 코포레이션 | 세포내 생물발광 공명 에너지 전이를 이용하여 생물활성제에 의한 세포 표적 결합의 인식 |
| SG11201504520XA (en) | 2012-12-12 | 2015-07-30 | Promega Corp | Compositions and methods for capture of cellular targets of bioactive agents |
| JP6511720B2 (ja) | 2013-02-28 | 2019-05-15 | Jnc株式会社 | コドン最適化変異エビルシフェラーゼ遺伝子およびその使用方法 |
| JP6604938B2 (ja) | 2013-03-15 | 2019-11-13 | プロメガ コーポレイション | タンパク質を官能基または固体表面に共有結合的に係留するための基質 |
| CA2906063A1 (en) | 2013-03-15 | 2014-09-25 | Promega Corporation | Activation of bioluminescence by structural complementation |
| US10168323B2 (en) | 2013-03-15 | 2019-01-01 | Promega Corporation | Compositions and methods for capture of cellular targets of bioactive agents |
| EP2978857A2 (en) | 2013-03-27 | 2016-02-03 | Sample Technologies, Inc. | Recombinant phage and bacterial detection methods |
| JP6040846B2 (ja) * | 2013-04-08 | 2016-12-07 | Jnc株式会社 | セレンテラジン類縁体 |
| CA2915820A1 (en) | 2013-06-19 | 2014-12-24 | Michael Sandor Koeris | Phage-based bacterial detection assay |
| AU2014287005C1 (en) * | 2013-07-12 | 2021-06-03 | The Children's Hospital Of Philadelphia | AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodies |
| WO2015007317A1 (en) | 2013-07-18 | 2015-01-22 | Ecole polytechnique fédérale de Lausanne (EPFL) | Means and methods for bioluminescence resonance energy transfer (bret) analysis in a biological sample |
| JP6484987B2 (ja) | 2013-10-21 | 2019-03-20 | Jnc株式会社 | エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法 |
| WO2015067302A1 (en) | 2013-11-05 | 2015-05-14 | Ecole Polytechnique Federale De Lausanne (Epfl) | Sensor molecules and uses thereof |
| JP6442825B2 (ja) * | 2013-12-26 | 2018-12-26 | Jnc株式会社 | エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法 |
| US9927430B2 (en) | 2014-01-29 | 2018-03-27 | Promega Corporation | Pro-substrates for live cell applications |
| US9790537B2 (en) | 2014-01-29 | 2017-10-17 | Promega Corporation | Quinone-masked probes as labeling reagents for cell uptake measurements |
| JP6256118B2 (ja) * | 2014-03-11 | 2018-01-10 | Jnc株式会社 | エビルシフェラーゼの触媒蛋白質のキメラ遺伝子及びその使用法 |
| JP6265020B2 (ja) * | 2014-04-16 | 2018-01-24 | Jnc株式会社 | エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法 |
| WO2015179864A1 (en) | 2014-05-23 | 2015-11-26 | Promega Corporation | Compositions and methods for stabilizing luminogenic substrates |
| EP3191600A1 (en) | 2014-09-11 | 2017-07-19 | Promega Corporation | Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence |
| EP3191601B1 (en) * | 2014-09-12 | 2022-11-02 | Promega Corporation | Internal protein tags |
| US11365402B2 (en) * | 2014-09-12 | 2022-06-21 | Promega Corporation | Internal protein tags |
| WO2016098078A2 (en) * | 2014-12-19 | 2016-06-23 | Novartis Ag | Dimerization switches and uses thereof |
| EP4455668A3 (en) | 2015-02-05 | 2025-02-19 | Promega Corporation | Luciferase-based thermal shift assays |
| US10618907B2 (en) | 2015-06-05 | 2020-04-14 | Promega Corporation | Cell-permeable, cell-compatible, and cleavable linkers for covalent tethering of functional elements |
| CN107922428B (zh) | 2015-06-25 | 2021-02-05 | 普洛麦格公司 | 噻吩并吡咯化合物及其作为刺虾源性荧光素酶的抑制剂的用途 |
| US20170029798A1 (en) * | 2015-07-27 | 2017-02-02 | Cellivery Therapeutics, Inc. | Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD) |
| US9924073B2 (en) * | 2016-02-15 | 2018-03-20 | Promega Corporation | Substituted imidazo[1,2-a]pyrazines as luciferase substrates and preparation method thereof |
| US11015176B2 (en) | 2016-03-11 | 2021-05-25 | National Institute Of Advanced Industrial Science And Technology | Nucleic acid encoding a luminescent enzyme protein |
| WO2017189751A1 (en) | 2016-04-26 | 2017-11-02 | The University Of Utah Research Foundation | Target-binding activated split reporter systems for analyte detection and related components and methods |
| CN105968114B (zh) * | 2016-05-27 | 2018-11-09 | 山东大学 | 一种腔肠素类似物及其制备方法与应用 |
| EP3490991B1 (en) | 2016-07-28 | 2021-01-06 | Promega Corporation | Coelenterazine analogues |
| US10202584B2 (en) * | 2016-09-01 | 2019-02-12 | The Regents Of The University Of California | Red-shifted luciferase-luciferin pairs for enhanced bioluminescence |
| WO2018049241A1 (en) | 2016-09-09 | 2018-03-15 | Promega Corporation | Dual protected pro-coelenterazine substrates |
| US10280447B2 (en) | 2016-11-01 | 2019-05-07 | Promega Corporation | Substituted imidazo[1,2-A]pyrazines tethered to energy acceptors |
| US10400264B2 (en) * | 2016-12-01 | 2019-09-03 | Promega Corporation | 5,5-disubstituted luciferins and their use in luciferase-based assays |
| JP7139330B2 (ja) * | 2016-12-01 | 2022-09-20 | プロメガ コーポレイション | 細胞不透過性セレンテラジンアナログ |
| JP7161475B2 (ja) | 2016-12-28 | 2022-10-26 | プロメガ コーポレイション | 官能化ｎａｎｏｌｕｃ阻害剤 |
| WO2018219953A1 (en) | 2017-05-30 | 2018-12-06 | Ecole polytechnique fédérale de Lausanne (EPFL) | Sensors, methods and kits for detecting nadph based on resonance energy transfer. |
| US10836767B2 (en) | 2017-07-06 | 2020-11-17 | Promega Corporation | Serum stable pro-coelenterazine analogues |
| CN108107209B (zh) * | 2017-09-19 | 2020-07-24 | 中国中医科学院医学实验中心 | 一种检测分泌型报告蛋白含量的优化方法及其所用生物材料 |
| US11655247B2 (en) | 2018-05-01 | 2023-05-23 | Promega Corporation | Nanoluc suicide substrates |
| JP7432529B2 (ja) | 2018-05-30 | 2024-02-16 | プロメガ コーポレイション | 広域スペクトルキナーゼ結合剤 |
| WO2019232384A1 (en) | 2018-06-01 | 2019-12-05 | Promega Corporation | Inhibitors of oplophorus luciferase-derived bioluminescent complexes |
| US10962538B2 (en) | 2018-06-14 | 2021-03-30 | The Trustees Of Columbia University In The City Of New York | Assays using arrestin recruitment and unmodified receptors |
| US11857638B2 (en) | 2018-07-27 | 2024-01-02 | Promega Corporation | Quinone-containing conjugates |
| KR20210049854A (ko) * | 2018-08-23 | 2021-05-06 | 프로메가 코포레이션 | 코엘렌테라진 유사체 |
| KR102773160B1 (ko) | 2018-10-03 | 2025-03-04 | 프로메가 코포레이션 | 코엘렌테라진 및 이의 유사체 및 유도체를 안정화하기 위한 조성물 및 방법 |
| WO2020113036A2 (en) | 2018-11-28 | 2020-06-04 | Promega Corporation | Reactive peptide labeling |
| US20200200765A1 (en) | 2018-12-04 | 2020-06-25 | Promega Corporation | Broad spectrum gpcr binding agents |
| US20220259574A1 (en) * | 2019-02-27 | 2022-08-18 | University Of Virginia Patent Foundation | Atp-independent bioluminescent reporter variants to improve in vivo imaging |
| US11913944B2 (en) | 2019-03-20 | 2024-02-27 | Promega Corporation | Photoaffinity probes |
| US11360096B2 (en) | 2019-05-16 | 2022-06-14 | Duke University | Complex BRET technique for measuring biological interactions |
| US20200399660A1 (en) | 2019-06-24 | 2020-12-24 | Promega Corporation | Modified polyamine polymers for delivery of biomolecules into cells |
| KR20220121816A (ko) | 2019-11-27 | 2022-09-01 | 프로메가 코포레이션 | 다분할 루시퍼라제 펩타이드 및 폴리펩타이드 |
| EP4073512A1 (en) | 2019-12-10 | 2022-10-19 | Promega Corporation | Compositions and methods for bioluminescent detection using multifunctional probes |
| US20230288338A1 (en) * | 2020-03-17 | 2023-09-14 | National Institute Of Advanced Industrial Science And Technology | Luminescent substrate compound |
| EP3882632A1 (en) | 2020-03-18 | 2021-09-22 | Universite De Bordeaux | Novel ion conducting channel fusion subunits and methods of use thereof |
| CN113527231A (zh) * | 2020-04-15 | 2021-10-22 | 深圳华大生命科学研究院 | 杂环取代腔肠素类化合物的合成方法 |
| EP3904508A1 (en) | 2020-04-27 | 2021-11-03 | Institut Pasteur | Luciferase linked immunosorbent assay |
| WO2021237118A2 (en) | 2020-05-22 | 2021-11-25 | Promega Corporation | Enhancement of kinase target engagement |
| JP2023540934A (ja) | 2020-08-28 | 2023-09-27 | プロメガ コーポレイション | Ｒａｓタンパク質のターゲットエンゲージメントアッセイ |
| KR20230124938A (ko) | 2020-12-25 | 2023-08-28 | 추가이 세이야쿠 가부시키가이샤 | 복수의 표적 분자와 함께 복합체를 형성할 수 있는후보 분자의 스크리닝 방법 |
| CN118703457A (zh) * | 2021-04-01 | 2024-09-27 | 深圳华大生命科学研究院 | 一种刺虾荧光素酶Nluc的突变体及其应用 |
| CN118139895A (zh) * | 2021-08-24 | 2024-06-04 | 巴斯德研究所 | 基于发光的抗原测定法 |
| WO2023215452A2 (en) | 2022-05-04 | 2023-11-09 | Promega Corporation | Split modified dehalogenase variants |
| EP4519425A1 (en) | 2022-05-04 | 2025-03-12 | Promega Corporation | Modified dehalogenase with extended surface loop regions |
| WO2023215514A2 (en) | 2022-05-04 | 2023-11-09 | Promega Corporation | Bioluminescence-triggered photocatalytic labeling |
| US20240060059A1 (en) | 2022-05-04 | 2024-02-22 | Promega Corporation | Circularly permuted dehalogenase variants |
| CN115349611B (zh) * | 2022-08-05 | 2023-10-24 | 江南大学 | 一种改善南美白对虾虾糜凝胶品质的方法 |
| CN116068198B (zh) * | 2022-11-30 | 2024-01-09 | 深圳湾实验室 | Ppi原位检测方法及其载体、诊断试剂、试剂盒和应用 |
| US20240377404A1 (en) * | 2023-03-24 | 2024-11-14 | Promega Corporation | Bioluminescence-triggered photocatalytic activation |
| JP7482563B1 (ja) | 2023-06-21 | 2024-05-14 | 国立大学法人大阪大学 | シイノトモシビタケ由来の発光関連遺伝子 |
| DE102023120682B3 (de) | 2023-08-03 | 2024-10-24 | Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut | Zytotoxizitätstest zum Nachweis von Zellschäden |
| GB202404021D0 (en) | 2024-03-20 | 2024-05-01 | Ipsen Biopharm Ltd | Cell-based neurotoxin assay |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0134108B1 (en) | 1983-08-17 | 1989-04-05 | AlliedSignal Inc. | Gas generator and method of generating gas |
| JPH0515398A (ja) | 1991-07-15 | 1993-01-26 | Nippon Oil & Fats Co Ltd | オキシダーゼ酵素の定量方法 |
| US5368484A (en) | 1992-05-22 | 1994-11-29 | Atari Games Corp. | Vehicle simulator with realistic operating feedback |
| US6387675B1 (en) | 1994-01-03 | 2002-05-14 | Promega Corporation | Mutant luciferases |
| EP1978091A1 (en) | 1994-01-03 | 2008-10-08 | Promega Corporation | Mutant luciferases |
| GB9501170D0 (en) | 1994-03-23 | 1995-03-08 | Secr Defence | Luciferases |
| JP3648763B2 (ja) | 1994-08-23 | 2005-05-18 | 日本油脂株式会社 | ウミホタルルシフェリン誘導体および糖加水分解酵素の定量方法 |
| GB9417593D0 (en) | 1994-09-01 | 1994-10-19 | Secr Defence | Luciferase labelling method |
| US5670356A (en) | 1994-12-12 | 1997-09-23 | Promega Corporation | Modified luciferase |
| CA2210354C (en) | 1995-01-20 | 2008-01-08 | The Secretary Of State For Defence | Mutant luciferases |
| JPH08294397A (ja) | 1995-04-27 | 1996-11-12 | Nippon Oil & Fats Co Ltd | 免疫学的活性物質の測定方法 |
| US5998204A (en) | 1997-03-14 | 1999-12-07 | The Regents Of The University Of California | Fluorescent protein sensors for detection of analytes |
| GB9707486D0 (en) | 1997-04-11 | 1997-05-28 | Secr Defence | Enzyme assays |
| US6429286B1 (en) | 1997-04-16 | 2002-08-06 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Immunoregulatory molecules for costimulatory signal transduction |
| JP4537573B2 (ja) | 1997-09-19 | 2010-09-01 | プロメガ・コーポレイシヨン | 熱安定ルシフェラーゼと生産方法 |
| US6602677B1 (en) | 1997-09-19 | 2003-08-05 | Promega Corporation | Thermostable luciferases and methods of production |
| GB9823468D0 (en) | 1998-10-28 | 1998-12-23 | Secr Defence | Novel enzyme |
| JP3694181B2 (ja) | 1999-01-05 | 2005-09-14 | キッコーマン株式会社 | 変異型ルシフェラーゼ、変異型ルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ルシフェラーゼの製造法 |
| GB9925161D0 (en) | 1999-10-26 | 1999-12-22 | Secr Defence | Novel enzyme |
| ES2292479T3 (es) * | 1999-10-26 | 2008-03-16 | The Secretary Of State For Defence | Luciferasa mutante. |
| US20010046687A1 (en) | 2000-03-31 | 2001-11-29 | Dicesare Joseph L. | Method for the enhancement of luminescence intensity from a reaction between adenosine triphosphate (ATP) and a luciferase/luciferin reactant system |
| DE60142761D1 (de) | 2000-04-26 | 2010-09-23 | Chisso Corp | Oplophorus Luciferase |
| JP4613441B2 (ja) * | 2000-04-26 | 2011-01-19 | チッソ株式会社 | 新規ルシフェラーゼおよび発光蛋白質 |
| US7118878B1 (en) | 2000-06-09 | 2006-10-10 | Promega Corporation | Method for increasing luminescence assay sensitivity |
| US7879540B1 (en) | 2000-08-24 | 2011-02-01 | Promega Corporation | Synthetic nucleic acid molecule compositions and methods of preparation |
| US7268229B2 (en) * | 2001-11-02 | 2007-09-11 | Promega Corporation | Compounds to co-localize luminophores with luminescent proteins |
| AU2003216139B2 (en) | 2002-02-01 | 2008-08-14 | Promega Corporation | Bioluminescent protease assay |
| JP2006508339A (ja) | 2002-09-20 | 2006-03-09 | プロメガ コーポレイション | シトクロムｐ４５０活性を測定するための発光を利用する方法およびプローブ |
| ATE290016T1 (de) | 2002-10-21 | 2005-03-15 | Axxam S R L | Photoprotein mit verbesserter biolumineszenz |
| AU2003300008B2 (en) | 2002-12-23 | 2007-04-05 | Promega Corporation | Improved luciferase-based assays |
| US7429472B2 (en) | 2003-01-31 | 2008-09-30 | Promega Corporation | Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule |
| EP2369006B1 (en) | 2003-01-31 | 2014-03-12 | Promega Corporation | Covalent tethering of functional groups to proteins |
| EP1592805A1 (en) | 2003-02-12 | 2005-11-09 | Promega Corporation | Methods and kits for dual enzymatic assays whereby light is quenched from luminescent reactions |
| US20040178545A1 (en) | 2003-03-14 | 2004-09-16 | Cates Larry E. | System for optically analyzing a molten metal bath |
| EP2308978B8 (en) | 2003-10-10 | 2015-04-08 | Promega Corporation | Luciferase biosensor |
| ATE443070T1 (de) | 2004-01-08 | 2009-10-15 | Univ Zuerich | Metallkomplexe mit vitamin b12 als ligand |
| US7416854B2 (en) | 2004-01-22 | 2008-08-26 | Promega Corporation | Luminogenic and nonluminogenic multiplex assay |
| US7553632B2 (en) | 2004-01-22 | 2009-06-30 | Promega Corporation | Luminogenic and nonluminogenic multiplex assay |
| EP3179252B1 (en) | 2004-07-30 | 2018-11-14 | Promega Corporation | Covalent tethering of functional groups to proteins and substrates therefor |
| US20070087400A1 (en) | 2004-07-30 | 2007-04-19 | Aldis Darzins | Covalent tethering of functional groups to proteins and substrates therefor |
| US7425436B2 (en) | 2004-07-30 | 2008-09-16 | Promega Corporation | Covalent tethering of functional groups to proteins and substrates therefor |
| US7728118B2 (en) | 2004-09-17 | 2010-06-01 | Promega Corporation | Synthetic nucleic acid molecule compositions and methods of preparation |
| JP4639904B2 (ja) | 2005-03-30 | 2011-02-23 | チッソ株式会社 | 蛍光活性を有するルシフェラーゼの活性増強方法 |
| JP3844082B2 (ja) * | 2005-04-08 | 2006-11-08 | キッコーマン株式会社 | 耐熱性ホタルルシフェラーゼ、耐熱性ホタルルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ及び耐熱性ホタルルシフェラーゼの製造法 |
| US7951550B2 (en) | 2005-05-31 | 2011-05-31 | Promega Corporation | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| EP1935986B1 (en) | 2005-05-31 | 2014-04-16 | Promega Corporation | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| US7495579B2 (en) | 2005-06-13 | 2009-02-24 | Sirota J Marcos | Traffic light status remote sensor system |
| EP1915457A4 (en) | 2005-08-17 | 2010-01-27 | Yeda Res & Dev | METHODS AND COMPOSITIONS FOR DETERMINING THE PARAOXONASE LEVEL OF THE ACTIVE SERUM ON THE BIOLOGICAL PLAN |
| JP4999341B2 (ja) * | 2005-09-06 | 2012-08-15 | 株式会社バイオエネックス | 変異型ホタルルシフェラーゼ、遺伝子、組換えベクター、形質転換体、及び変異型ホタルルシフェラーゼの製造方法 |
| WO2007120522A2 (en) | 2006-04-03 | 2007-10-25 | Promega Corporation | Permuted and nonpermuted luciferase biosensors |
| JP2007306871A (ja) | 2006-05-19 | 2007-11-29 | Chisso Corp | 封入体可溶化方法及び精製方法 |
| EP2087107A2 (en) | 2006-10-30 | 2009-08-12 | Promega Corporation | Mutant hydrolase proteins with enhanced kinetics and functional expression |
| WO2008086035A2 (en) | 2007-01-10 | 2008-07-17 | Promega Corporation | Split mutant hydrolase fusion reporter and uses thereof |
| US20080248511A1 (en) | 2007-03-26 | 2008-10-09 | Promega Corporation | Methods to quench light from optical reactions |
| JP2011502509A (ja) | 2007-11-05 | 2011-01-27 | プロメガ コーポレイション | ハイブリッド融合レポーター及びその使用 |
| JP6110591B2 (ja) | 2008-05-19 | 2017-04-05 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | ｃＡＭＰのためのルシフェラーゼバイオセンサー |
| EP2326953B1 (en) | 2008-07-22 | 2018-03-21 | Promega Corporation | Adp detection based luminescent phosphotransferase or atp hydrolase assay |
| TWI375901B (en) | 2008-08-05 | 2012-11-01 | Elan Microelectronics Corp | Touch screen and method for positioning coordinate |
| WO2010090319A1 (ja) * | 2009-02-09 | 2010-08-12 | チッソ株式会社 | セレンテラジン類縁体及びその製造方法 |
| EP2420573A1 (en) * | 2009-04-17 | 2012-02-22 | National Institute of Advanced Industrial Science And Technology | Stable artificial bioluminescent enzyme having super-high brightness |
| SG10201601281WA (en) | 2009-05-01 | 2016-03-30 | Promega Corp | Synthetic oplophorus luciferases with enhanced light output |
| WO2011038219A1 (en) | 2009-09-24 | 2011-03-31 | Promega Corporation | Proteases having improved stability, solubility and activity |
| JP5605727B2 (ja) * | 2010-04-06 | 2014-10-15 | Ｊｎｃ株式会社 | セレンテラジン類縁体及びセレンテラミド類縁体 |
| EP2990479B1 (en) | 2010-05-11 | 2019-03-27 | Promega Corporation | Mutant protease biosensors with enhanced detection characteristics |
| EP2611929B1 (en) | 2010-09-01 | 2016-01-13 | Promega Corporation | Oxidized glutathione assay |
| US9284188B2 (en) | 2010-09-03 | 2016-03-15 | The Regents Of The University Of California | Cytosolic delivery of materials with endosome-disrupting colloids |
| BR112013010855A2 (pt) | 2010-11-02 | 2017-06-27 | Promega Corp | luciferases derivadas de oplophorus, novos substratos de coelenterazina e métodos de uso |
| PT2635583E (pt) | 2010-11-02 | 2015-09-11 | Promega Corp | Derivados da coelenterazina e métodos de utilização da mesma |
| US9273343B2 (en) | 2011-09-02 | 2016-03-01 | Promega Corporation | Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H |
-
2011
- 2011-11-02 BR BR112013010855A patent/BR112013010855A2/pt not_active Application Discontinuation
- 2011-11-02 CA CA3081115A patent/CA3081115A1/en active Pending
- 2011-11-02 CN CN201180062485.1A patent/CN103370319B/zh active Active
- 2011-11-02 ES ES11782732T patent/ES2567410T3/es active Active
- 2011-11-02 BR BR112013010487-2A patent/BR112013010487B1/pt active IP Right Grant
- 2011-11-02 WO PCT/US2011/059018 patent/WO2012061530A2/en active Application Filing
- 2011-11-02 KR KR1020137014102A patent/KR101538624B1/ko active Active
- 2011-11-02 PL PL11785534T patent/PL2635595T3/pl unknown
- 2011-11-02 AU AU2011323418A patent/AU2011323418B2/en active Active
- 2011-11-02 SG SG10202103336SA patent/SG10202103336SA/en unknown
- 2011-11-02 JP JP2013537799A patent/JP5889910B2/ja active Active
- 2011-11-02 KR KR1020137014030A patent/KR101939553B1/ko active Active
- 2011-11-02 ES ES11785534T patent/ES2723773T3/es active Active
- 2011-11-02 US US13/287,986 patent/US8669103B2/en active Active
- 2011-11-02 EP EP11782732.9A patent/EP2635582B1/en active Active
- 2011-11-02 US US13/287,992 patent/US8809529B2/en active Active
- 2011-11-02 EP EP19150036.2A patent/EP3498709A1/en active Pending
- 2011-11-02 JP JP2013537800A patent/JP6155424B2/ja active Active
- 2011-11-02 EP EP19150069.3A patent/EP3498710A1/en active Pending
- 2011-11-02 DK DK11782732.9T patent/DK2635582T3/da active
- 2011-11-02 CA CA2817102A patent/CA2817102C/en active Active
- 2011-11-02 SG SG10201607774RA patent/SG10201607774RA/en unknown
- 2011-11-02 CN CN201610172245.1A patent/CN106148362B/zh active Active
- 2011-11-02 SG SG10201608550SA patent/SG10201608550SA/en unknown
- 2011-11-02 DK DK11785534.6T patent/DK2635595T3/en active
- 2011-11-02 CN CN201180063659.6A patent/CN103443121B/zh active Active
- 2011-11-02 PT PT11785534T patent/PT2635595T/pt unknown
- 2011-11-02 EP EP11785534.6A patent/EP2635595B1/en active Active
- 2011-11-02 SG SG2013033675A patent/SG190104A1/en unknown
- 2011-11-02 PL PL11782732T patent/PL2635582T3/pl unknown
- 2011-11-02 WO PCT/US2011/059017 patent/WO2012061529A1/en active Application Filing
- 2011-11-02 CA CA2815227A patent/CA2815227C/en active Active
- 2011-11-02 SG SG2013030366A patent/SG189496A1/en unknown
-
2013
- 2013-04-21 IL IL225867A patent/IL225867B/en active IP Right Grant
- 2013-05-02 IL IL226114A patent/IL226114B/en active IP Right Grant
-
2014
- 2014-01-21 US US14/160,278 patent/US9840730B2/en active Active
- 2014-01-21 US US14/160,282 patent/US9951373B2/en active Active
- 2014-08-18 US US14/461,610 patent/US9139836B2/en active Active
-
2015
- 2015-09-21 US US14/859,715 patent/US9938564B2/en active Active
-
2016
- 2016-02-12 JP JP2016024952A patent/JP6374420B2/ja active Active
- 2016-02-17 JP JP2016028303A patent/JP6574721B2/ja active Active
- 2016-08-12 AU AU2016213854A patent/AU2016213854B2/en active Active
-
2017
- 2017-04-21 JP JP2017084390A patent/JP6539689B2/ja active Active
-
2018
- 2018-03-06 JP JP2018040100A patent/JP6752839B2/ja active Active
- 2018-04-09 US US15/948,070 patent/US10774364B2/en active Active
- 2018-04-18 IL IL258790A patent/IL258790B/en active IP Right Grant
-
2020
- 2020-04-28 IL IL274316A patent/IL274316B/en unknown
- 2020-09-03 US US17/011,597 patent/US11661623B2/en active Active
-
2021
- 2021-05-27 US US17/332,459 patent/US12215375B2/en active Active
- 2021-11-14 IL IL288070A patent/IL288070B2/en unknown
-
2023
- 2023-09-21 US US18/471,901 patent/US20240158831A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288070A (en) | Luciferases derived from Eulophorus, new coelantrazine materials and methods of use | |
| IL248530A0 (en) | Biomarkers and treatment methods | |
| IL247595A0 (en) | New modulators and methods of use | |
| IL222227A0 (en) | Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use | |
| IL225869A (en) | Colentrazine derivatives and methods for their use | |
| ZA201300612B (en) | Novel bacteria and methods of use thereof | |
| EP2616442B8 (en) | Inhibitors of pi3k-delta and methods of their use and manufacture | |
| ZA201209205B (en) | Pyridone and aza-pyridone compounds and methods of use | |
| EP2539005A4 (en) | ORAL PIECE AND METHODS OF USING THE SAME | |
| EP2529079A4 (en) | SELF-HARDENING HIGH STRENGTH SUPPORT AND MANUFACTURING METHOD THEREFOR | |
| SG10201601792UA (en) | Novel modulators and methods of use | |
| EP2536283B8 (en) | Phenyl-heteroaryl derivatives and methods of use thereof | |
| IL225227A0 (en) | Preparations including fulvestrant and methods of use | |
| EP2464227A4 (en) | COMPOUNDS AND METHODS OF USE | |
| GB2479023B (en) | Construction panel and method of use thereof | |
| GB2478317B (en) | Herbicidal composition and method of use thereof | |
| EP2649096A4 (en) | HEMOGLOBIN COMPOSITIONS AND METHODS OF USE | |
| HK40090436A (en) | Cd40l-specific tn3-derived scaffolds and methods of use thereof | |
| HK1177747A (en) | Hsa-related compositions and methods of use | |
| ZA201301175B (en) | Biomarkers and methods of treatment | |
| AU2010900187A0 (en) | Methods of Treatment and Immunotherapy | |
| HK1187109A (zh) | 生物標記物和處理方法 | |
| HK1187900A (en) | Inhibitors of pi3k-delta and methods of their use and manufacture | |
| HK1187899A (en) | Inhibitors of pi3k-delta and methods of their use and manufacture | |
| HK1201463B (en) | Cd40l-specific tn3-derived scaffolds and methods of use thereof |